Statewide Practice Enhances Genomic Testing to Advance Cancer Care

Florida Cancer Specialists & Research Institute (FCS), a leading community oncology practice, has continued to enhance its genomic testing capabilities to advance cancer care, improve cure rates, and enhance patient experience. The practice has made significant progress in expanding its comprehensive genomic testing menu, which includes liquid biopsy, a blood test that detects signs of cancerous tumors and cells traveling in the bloodstream. This advancement reflects the practice's commitment to leveraging innovative technologies to deliver world-class care and drive better clinical outcomes for cancer patients.

Key Takeaways:

• FCS has launched liquid biopsy, a minimally invasive blood test that detects signs of cancerous tumors and cells traveling in the bloodstream, offering significant benefits in the diagnosis and treatment of common cancers, such as lung, colorectal, breast, and prostate cancer.
• The practice has expanded its comprehensive genomic testing menu, which includes next-generation sequencing (NGS) capabilities, up to 16,000 molecular tests processed at its state-of-the-art laboratory facility in Fort Myers, and over 4.2 million visits annually across Florida.
• FCS has established partnerships with global technology and software leaders, such as Illumina, to optimize clinical decision making and advance precision oncology.
• The practice's clinical team has expanded to include three board-certified genetic scientists and several licensed genetic and molecular scientists, ensuring high-quality testing and results.
• FCS has surpassed 16,000 molecular tests processed and 4.2 million visits annually across Florida, demonstrating its commitment to delivering world-class care and driving better clinical outcomes.

Statistics:

• FCS has processed over 16,000 molecular tests at its state-of-the-art laboratory facility in Fort Myers.
• The practice serves over 250 physicians and more than 102,000 patients annually across Florida, with over 4.2 million visits annually.
• FCS has established partnerships with prominent technology and software leaders to advance precision oncology.

Sources:

• "Florida Cancer Specialists & Research Institute" (Press Release, June 9, 2025)
• Florida Cancer Specialists & Research Institute (FCS) website